Clinical Trial Update: Levodopa Benserazide Generic Formulation Versus the Originator [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing a generic levodopa/benserazide formulation to the originator in Parkinson disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• levodopa benserazide (generic formulation) (levodopa benserazide)

Snippet

Sponsor: IRCCS San Raffaele Roma | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED